AN2 Therapeutics, Inc.
ANTX
Výsledovka
Rozvaha
Peněžní toky
Ukazatele
Klíčové metriky
V miliónech (USD)
| Revenue | TTM | 2024 | 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|---|---|---|
| Total Revenues | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Cost of Revenues | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Gross Profit | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Operating Income | TTM | 2024 | 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|---|---|---|
| R&D Expenses | 0.00 | 0.00 | 54,871.00 | 29,511.00 | 16,906.00 | 6,019.00 | |
| Selling General & Admin Expenses | 0.00 | 0.00 | 14,764.00 | 12,751.00 | 4,668.00 | 1,265.00 | |
| Depreciation & Amortization | 8,607.00 | 54,554.00 | 69,635.00 | 0.00 | 0.00 | 0.00 | |
| Total Operating Expenses | 37,391.00 | 54,554.00 | 69,635.00 | 42,262.00 | 21,574.00 | 7,284.00 | |
| Operating Income | -37,391.00 | -54,554.00 | -69,635.00 | -42,262.00 | -21,574.00 | -7,284.00 | |
| Net Income | TTM | 2024 | 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|---|---|---|
| Interest Income | 2,329.00 | 5,467.00 | 0.00 | 1,351.00 | 69.00 | 3.00 | |
| Interest Expense | 0.00 | 0.00 | 0.00 | 514.00 | 0.00 | 0.00 | |
| Other Expense | 3,405.00 | 3,233.00 | 4,903.00 | 1,306.00 | 31.00 | -6,319.00 | |
| IBT | -33,986.00 | -51,321.00 | -64,732.00 | -40,956.00 | -21,543.00 | -13,603.00 | |
| Income Tax Expense | 0.00 | 0.00 | 0.00 | 514.00 | -69.00 | -3.00 | |
| Net Income | -33,986.00 | -51,321.00 | -64,732.00 | -41,470.00 | -21,474.00 | -13,600.00 | |
| Per Share Data | TTM | 2024 | 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|---|---|---|
| EPS | $0.00 | $0.00 | $-2.74 | $-2.70 | $-1.18 | $-0.97 | |
| EPS Diluted | $0.00 | $0.00 | $-2.74 | $-2.70 | $-1.18 | $-0.97 | |
| Shares Outstanding | 30,276.23 | 29,828.00 | 23,600.11 | 15,340.13 | 18,139.79 | 14,047.68 | |
| Diluted Shares Outstanding | 30,276.23 | 29,828.00 | 23,600.11 | 15,340.13 | 18,139.79 | 14,047.68 | |
| Current Assets | TTM | 2024 | 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|---|---|---|
| Cash And Equivalents | 26,769.00 | 21,351.00 | 15,647.00 | 27,219.00 | 12,097.00 | 4,070.00 | |
| Short Term Investments | 77,771.00 | 62,267.00 | 91,648.00 | 68,840.00 | 46,458.00 | 0.00 | |
| Total Cash & ST Investments | 104,540.00 | 83,618.00 | 107,295.00 | 96,059.00 | 58,555.00 | 4,070.00 | |
| Accounts Receivable | 300.00 | 300.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Inventory | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Other Current Assets | 2,598.00 | 2,344.00 | 3,212.00 | 2,562.00 | 1,551.00 | 164.00 | |
| Total Current Assets | 107,438.00 | 86,262.00 | 110,507.00 | 98,621.00 | 60,106.00 | 4,234.00 | |
| Long-Term Assets | TTM | 2024 | 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|---|---|---|
| Net Property, Plant & Equipment | 0.00 | 0.00 | 0.00 | 53.00 | 0.00 | 0.00 | |
| Goodwill | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Intangible Assets | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Long-Term Investments | 0.00 | 5,021.00 | 27,194.00 | 3,219.00 | 3,486.00 | 0.00 | |
| Other Long-Term Assets | 1,043.00 | 804.00 | 1,043.00 | 667.00 | 1,724.00 | 0.00 | |
| Total Long-Term Assets | 1,043.00 | 5,825.00 | 28,237.00 | 3,939.00 | 5,210.00 | 0.00 | |
| Total Assets | 108,481.00 | 92,087.00 | 138,744.00 | 102,560.00 | 65,316.00 | 4,234.00 | |
| Current Liabilities | TTM | 2024 | 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|---|---|---|
| Accounts Payable | 1,885.00 | 3,317.00 | 2,676.00 | 2,122.00 | 1,063.00 | 132.00 | |
| Short-Term Debt | 0.00 | 0.00 | 0.00 | 53.00 | 0.00 | 0.00 | |
| Other Current Liabilities | 8,242.00 | 6,921.00 | 11,367.00 | 5,011.00 | 2,332.00 | 1,327.00 | |
| Current Liabilities | 10,127.00 | 10,238.00 | 14,043.00 | 7,186.00 | 3,395.00 | 1,459.00 | |
| Long-Term Liabilities | TTM | 2024 | 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|---|---|---|
| Long-Term Debt | 0.00 | 0.00 | 0.00 | 53.00 | 0.00 | 0.00 | |
| Capital Leases | 0.00 | 0.00 | 0.00 | 53.00 | 0.00 | 0.00 | |
| Def. Tax Liability | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Total Liabilities | 10,127.00 | 10,238.00 | 14,043.00 | 7,188.00 | 112,727.00 | 24,553.00 | |
| Total Common Equity | TTM | 2024 | 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|---|---|---|
| Common Stock | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Retained Earnings | -185,507.00 | -205,776.00 | -154,455.00 | -89,723.00 | -47,384.00 | -20,319.00 | |
| Comprehensive Income | -27.00 | 31.00 | 275.00 | -374.00 | -27.00 | 0.00 | |
| Total Common Equity | 98,354.00 | 81,849.00 | 124,701.00 | 95,372.00 | -47,411.00 | -20,319.00 | |
| Cash Flow From Operating Activities | TTM | 2024 | 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|---|---|---|
| Net Income | -64,657.00 | -51,321.00 | -64,732.00 | -40,956.00 | -21,543.00 | -13,603.00 | |
| Depreciation & Amortization | 414.00 | 0.00 | 0.00 | -692.00 | 0.00 | 0.00 | |
| Stock-Based Compensation | 9,057.00 | 8,338.00 | 8,412.00 | 4,391.00 | 974.00 | 40.00 | |
| Change Working Capital | -1,318.00 | -2,995.00 | 5,834.00 | 3,718.00 | 32.00 | 1,224.00 | |
| Change In Accounts Receivable | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Change In Accounts Payable | -1,247.00 | 641.00 | 553.00 | 2,497.00 | 417.00 | 81.00 | |
| Change In Inventories | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Other Non-cash Items | 1,520.00 | -3,279.00 | -2,802.00 | 77.00 | 53.00 | 6,975.00 | |
| Cash from Operations | -60,845.00 | 0.00 | -53,288.00 | -33,462.00 | -20,484.00 | -5,364.00 | |
| Cash Flow From Investing Activities | TTM | 2024 | 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|---|---|---|
| Capital Expenditure | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Acquisitions | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Investments | -117,632.00 | -46,751.00 | -132,178.00 | -93,836.00 | -77,274.00 | 0.00 | |
| Sales of Investment | 98,340.00 | 101,340.00 | 88,900.00 | 72,065.00 | 27,250.00 | 0.00 | |
| Other Investing Activities | 26,227.96 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Cash from Investing | -19,292.00 | 0.00 | -43,278.00 | -21,771.00 | -50,024.00 | 0.00 | |
| Cash Flow From Financing Activities | TTM | 2024 | 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|---|---|---|
| Debt Repaid | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Debt Issued | -13.00 | 0.00 | -53.00 | 53.00 | 0.00 | 0.00 | |
| Issuance of Common Stock | 65,828.00 | 0.00 | 84,529.00 | 70,366.00 | 0.00 | 0.00 | |
| Repurchase of Common Stock | -0.32 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Dividends Paid | 0.00 | 0.00 | 0.00 | -1,820.00 | 0.00 | 0.00 | |
| Other Financing Activities | 19,740.00 | 0.00 | 465.00 | 1,809.00 | 78,535.00 | 0.00 | |
| Cash from Financing | 66,094.00 | 0.00 | 84,994.00 | 70,355.00 | 78,535.00 | 3,836.00 | |
| Cash position | TTM | 2024 | 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|---|---|---|
| Net Change in Cash | -14,043.00 | 5,704.00 | -11,572.00 | 15,122.00 | 8,027.00 | -1,528.00 | |
| Closing Cash Balance | 26,769.00 | 21,351.00 | 15,647.00 | 27,219.00 | 12,097.00 | 4,070.00 | |
| Free Cash Flow | TTM | 2024 | 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|---|---|---|
| Free Cash Flow | -60,845.00 | -49,257.00 | -53,288.00 | -33,462.00 | -20,484.00 | -5,364.00 | |
| Real Free Cash Flow | -69,902.00 | -57,595.00 | -61,700.00 | -37,853.00 | -21,458.00 | -5,404.00 | |
Placený obsah
Pro přístup na tuto stránku budete potřebovat placené členství.
Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.
